Correction: Fluidigm Closes on Sale of $201.3M of Senior Convertible Notes | GenomeWeb

Correction: The story has been updated to include the correct net proceed amount from the sale.

NEW YORK (GenomeWeb News) – Fluidigm said after the close of the market on Tuesday it has closed on the sale of about $201.3 million of senior convertible notes.

The sale was pursuant to an underwriting agreement between the South San Francisco, Calif.-based firm and Piper Jaffray. The notes are 2.75 percent senior convertible notes due in 2034.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of 200 bird species, and more.

The Australian High Court rules that isolated genetic material cannot be patented.

The startup incubator Y Combinator is launching a nonprofit research lab.

Wired's Sarah Zhang writes that the fight over who developed the CRISPR/Cas9 genome editing tool first underscores the history of parallel discoveries in science.